Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Assets
Cash and due from banks	$ 12,071,000	$ 12,709,000
Federal funds sold	80,545,000	30,742,000
Total cash and cash equivalents	92,616,000	43,451,000
Investment securities available for sale, at fair value	94,699,000	40,844,000
Restricted stock, at cost	694,000	825,000
Loans held for sale	5,141,000	34,421,000
Loans
Outstandings	526,457,000	561,003,000
Allowance for loan losses	(3,423,000)	(3,970,000)
Deferred fees and costs, net	(433,000)	(2,048,000)
Total loans, net	522,601,000	554,985,000
Other real estate owned, net of valuation allowance		336,000
Premises and equipment, net	11,824,000	11,779,000
Bank owned life insurance	12,494,000	7,806,000
Accrued interest receivable	3,245,000	4,943,000
Other assets	5,087,000	6,846,000
Total Assets	748,401,000	706,236,000
Deposits
Noninterest bearing demand	268,804,000	222,305,000
Interest bearing	395,244,000	366,077,000
Total deposits	664,048,000	588,382,000
Long-term debt - trust preferred securities	8,764,000	8,764,000
Subordinated debt, net	5,660,000	5,628,000
Other borrowings	0	41,529,000
Accrued interest payable	68,000	194,000
Other liabilities	6,460,000	9,743,000
Total liabilities	685,000,000	654,240,000
Shareholders' equity
Common stock, $4 par value, 10,000,000 shares authorized; 1,473,469 shares issued and outstanding at December 31, 2021 and 1,466,516 shares issued and outstanding at December 31, 2020	5,822,000	5,794,000
Additional paid-in capital	54,814,000	54,510,000
Retained earnings (accumulated deficit)	3,509,000	(8,738,000)
Stock in directors rabbi trust	(730,000)	(771,000)
Directors deferred fees obligation	730,000	771,000
Accumulated other comprehensive income (loss)	(744,000)	430,000
Total shareholders' equity	63,401,000	51,996,000
Total liabilities and shareholders' equity	$ 748,401,000	$ 706,236,000